Ocular Therapeutix, Inc. (OCUL) Social Stream



Ocular Therapeutix, Inc. (OCUL): $2.86

-0.04 (-1.38%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add OCUL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 378

in industry

OCULAR THERAPEUTIX INC (OCUL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering OCUL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 5 $30 $14 $20.833 $3.05 583.05%
2022-05-09 6 $30 $14 $20.833 $3.05 583.05%
2022-05-10 6 $30 $10 $19.5 $3.05 539.34%
2022-05-16 6 $30 $10 $18.833 $3.05 517.48%
2022-05-27 6 $30 $10 $17.833 $3.05 484.69%
2022-08-08 6 $30 $5 $16.5 $3.05 440.98%
2022-11-07 7 $29 $6.5 $15.785 $3.05 417.54%
2022-11-08 7 $25 $5 $13.285 $3.05 335.57%

The Trend in the Analyst Price Target


OCUL's average price target has moved down $12.04 over the prior 16 months.

Over the past 36 weeks, OCUL's average upside potential has been 383.22%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-27 6 30 10.0 17.833 3.19 459.03%
2022-05-27 6 30 10.0 18.800 3.19 489.34%
2022-08-10 7 29 6.5 15.785 5.81 171.69%
2022-08-22 7 29 6.5 15.785 5.17 205.32%
2022-11-07 7 29 6.5 15.785 3.55 344.65%

OCUL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 6 0 1 0 0 7

The Trend in the Broker Recommendations


Over the past 52 weeks, OCUL's average broker recommendation rating improved by 0.04.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, OCULAR THERAPEUTIX INC's upside potential (average analyst target price relative to current price) is higher than 1294.51% of them.
  • To contextualize these metrics, consider that out of all US stocks, OCULAR THERAPEUTIX INC's variance in analysts' estimates is lower than -1107.52% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, OCULAR THERAPEUTIX INC's number of analysts covering the stock is greater than 1099.23% of them.
  • In the context of Healthcare stocks, OCULAR THERAPEUTIX INC's average analyst price target is higher than 487.22% of them.

In the Pharmaceutical Products industry, CRBP, NERV, and PLXP are the three stocks most similar to OCULAR THERAPEUTIX INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding OCUL using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5737 seconds.